Glioblastoma and Other Primary Brain Malignancies in Adults

Short summary

Glioblastoma, the most common malignant brain tumor (49%), has a 2-year survival of 27.2% and 5-year survival of 9.8% when treated with temozolomide and radiotherapy, a significant improvement over radiotherapy alone (2-year survival 10.9%, 5-year survival 1.9%).

AI-generated from the title and abstract; the full text is not read.